ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2024 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
First line therapy for multiple sclerosis: cytokine levels and the impact of herpesvirus infection
About authors
1 Yaroslavl State Medical University, Yaroslavl, Russia
2 Pirogov Russian National Research Medical University, Moscow, Russia
Correspondence should be addressed: Natalia S. Baranova
Revolutsionnaya, 5, Yaroslavl, 150000, Russia; ur.liam@sn_avonarab
About paper
Funding: the study was supported by the Foundation for Assistance to Small Innovative Enterprises in Science and Technology (Innovation Promotion Foundation) within the framework of the program UMNIK: Participant of the Youth Research and Innovation Contest (contracts No. 3560GU1/2014 dated 23.09.2014, No. 8815GU2/2015 dated 17.12.2015).
Author contribution: Baranova NS, Gris MS — study planning and design; Gris MS, Artyuhov AS — data acquisition and research procedure; Baranova NS, Gris MS, Baranov AA — data analysis; all authors — data interpretation; Baranova NS, Gris MS — manuscript drafting; all authors — manuscript editing.
Compliance with ethical standards: the study was approved by the local Ethics Committee of the Yaroslavl State Medical University (protocol No. 1 dated 10 October 2013). The informed consent was submitted by all patients.
Received: 2024-04-23
Accepted: 2024-05-05
Published online: 2024-06-19
|
No data available...